Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products
about
Stimulation of equine eosinophil migration by hydroxyacid metabolites of arachidonic acidMacrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan.Recombinant interferon-gamma primes alveolar macrophages cultured in vitro for the release of leukotriene B4 in response to IgG stimulationLeukotrienes are involved in leukocyte recruitment induced by live Histoplasma capsulatum or by the beta-glucan present in their cell wallIncreased leukotriene B4 synthesis in immune injured rat glomeruli.Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.The type of dietary fat affects the severity of autoimmune disease in NZB/NZW mice.Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice.Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4.Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response.Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.A novel neutrophil-activating factor released by Trichomonas vaginalis.Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma.Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury.Studies on the activation of human neutrophil 5-lipoxygenase induced by natural agonists and Ca2+ ionophore A23187Leukotriene B4 and asthma.Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4.The contractile activities of lipoxin A4 and lipoxin B4 for guinea-pig airway tissuesThe inhibition of CR1 mobilization of human granulocytes by the presence of erythrocytes. A possible mechanism for intravascular regulation of granulocyte modulation.Leukotriene D4 induces chemotaxis in human eosinophilc cell line, EoL-1 cells via CysLT1 receptor activation.
P2860
Q28362659-633E4771-764F-4289-88AB-BA155821303FQ34263318-F663EEE9-4C54-4B24-A215-A223ED58D7B4Q34573260-44AED46F-6FFF-4116-919C-6D484CDFC541Q35041719-572C5D58-E682-4BB8-BF6E-08F640323764Q35590361-0E112EC4-54C9-434E-BDA8-4CACC999EC09Q35818264-9B47DAD4-1ACE-4EB5-922A-31C699B31B71Q35856009-4181A946-A1C7-4ACB-AC1D-D4FC661D84A1Q35921866-0ECA36D6-42D0-4F6F-A58D-C3B5282A8176Q36270108-E438D456-18E6-49BD-B5B7-ED8D94484ED8Q36348698-C4FD9328-103A-41BC-ABAF-EEDCAC8B3330Q36573372-E10840F6-B0B0-4C3C-8B62-197DCB8E455FQ36969469-E8BDB201-F94E-4DD2-9093-D9026EE55609Q37690942-2AE9E580-7351-4C6B-89C9-CFD5B836D04AQ40380559-D05D0AF6-8046-4E9D-8B7E-22117457AC28Q40920142-72D2EFFA-5EFA-4BE4-BFEB-808C7C040F5BQ41916569-446192CF-C6C6-47AE-9E8E-0AA19676C015Q42028772-14722F03-1336-4A76-9E6C-BF33F54C774BQ42423750-01B723D9-C2C2-4D03-A310-88CE8BCF5AB8Q42636309-0F85CF13-22E4-467B-BD5A-3505972580C8Q42848570-0EBF7660-52D5-43BF-B867-5595A2C0F9A6Q44561511-804C5486-C98F-49FF-BF48-2EA82EAD1FB2Q47139569-26139BA5-C970-4AE8-B979-4A2250116207
P2860
Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products
description
1982 nî lūn-bûn
@nan
1982 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի մարտին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
Complement receptor enhancemen ...... nd other lipoxygenase products
@ast
Complement receptor enhancemen ...... nd other lipoxygenase products
@en
Complement receptor enhancemen ...... nd other lipoxygenase products
@nl
type
label
Complement receptor enhancemen ...... nd other lipoxygenase products
@ast
Complement receptor enhancemen ...... nd other lipoxygenase products
@en
Complement receptor enhancemen ...... nd other lipoxygenase products
@nl
prefLabel
Complement receptor enhancemen ...... nd other lipoxygenase products
@ast
Complement receptor enhancemen ...... nd other lipoxygenase products
@en
Complement receptor enhancemen ...... nd other lipoxygenase products
@nl
P2093
P2860
P1476
Complement receptor enhancemen ...... nd other lipoxygenase products
@en
P2093
P2860
P407
P577
1982-03-01T00:00:00Z